Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis.

All potential biomarkers identified between the stages of fibrosis could be key points in determining the fibrosis staging. The differences between early stages may provide a useful reference in addressing the challenge of early fibrosis staging.